J&J consumer healthcare faces more issues, this time in Brazil

Johnson & Johnson ($JNJ) just can't seem to get its consumer health manufacturing in order. Already facing a criminal investigation in South Korea over children's Tylenol products, it is having to recall more than 3.3 million bottles of Tylenol Drops in Brazil, Pharmalot reports. This time, it says, there is a problem with the dropper that could lead to an overdose. Authorities in South Korea have indicated they have started a criminal investigation into problems at J&J's Janssen over-the-counter plant there. The probe means Kim Oak-yeon, CEO of the Johnson & Johnson subsidiary in South Korea, faces up to three years in jail if convicted. Authorities seem to be keying in on the fact that the Janssen unit continued to sell Children's Tylenol after discovering that manufacturing issues may have resulted in the products containing more than the labeled amounts of acetaminophen, a problem that can lead to liver damage. No adverse reactions were reported, and the company is working with authorities to resolve the issue. Story | More